"PATIENT_ID","LINE_NUMBER","LINE_NAME","START_DATE","END_DATE","LINE_TYPE","IS_MAINTENANCE","ADD_EXEMPTION","SUB_EXEMPTION","GAP_EXEMPTION","NAME_EXEMPTION","LINE_END_REASON","ENHANCED_COHORT","INDEX_DATE"
101,1,"Carboplatin,Pembrolizumab",2018-04-19,2018-12-27,"combo",FALSE,FALSE,FALSE,FALSE,FALSE,"New line started with new drugs","NSCLC",2018-04-19
101,2,"Carboplatin,Pembrolizumab,Pemetrexed",2019-01-24,2019-04-18,"combo",FALSE,FALSE,FALSE,FALSE,FALSE,"Last row hit","NSCLC",2018-04-19
2,1,"Nivolumab",2018-01-14,2018-02-18,"mono",FALSE,FALSE,FALSE,FALSE,FALSE,"New line started with new drugs","NSCLC",2018-01-14
2,2,"Carboplatin,Nivolumab",2018-03-04,2018-04-29,"combo",FALSE,FALSE,FALSE,FALSE,FALSE,"New line started with new drugs","NSCLC",2018-01-14
2,3,"Cetuximab",2018-05-14,2018-10-22,"mono",FALSE,FALSE,FALSE,FALSE,FALSE,"New line started with new drugs","NSCLC",2018-01-14
2,4,"Durvalumab",2018-11-12,2018-11-26,"mono",FALSE,FALSE,FALSE,FALSE,FALSE,"Last row hit","NSCLC",2018-01-14
4,1,"Carboplatin,Pembrolizumab,Pemetrexed",2020-01-01,2020-05-01,"combo",FALSE,FALSE,FALSE,FALSE,FALSE,"Last row hit","NSCLC",2020-01-01
